PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/211846 |
Resumo: | Solid dispersions (SDs) of ursolic acid (UA) were developed using polyvinylpyrrolidone K30 (PVP K30) in combination with non-ionic surfactants, such as D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) or poloxamer 407 (P407) with the aim of enhancing solubility and in vitro release of the UA. SDs were investigated using a 24 full factorial design, subsequently the selected formulations were characterized for water solubility, X-ray diffractometry (XRD), differential scanning calorimetry (DSC), particle diameter, scanning electron microscopy, drug content, physical-chemical stability and in vitro release profile. SDs showed higher UA water-solubility than physical mixtures (PMs), which was attributed by transition of the drug from crystalline to amorphous or molecular state in the SDs, as indicated by XRD and DSC analyses. SD1 (with P407) and SD2 (with TPGS) were chosen for further investigation because they had higher drug load. SD1 proved to be more stable than SD2, revealing that P407 contributed to ensure the stability of the UA. Furthermore, SD1 and SD2 increased UA release by diffusion and swelling-controlled transport, following the Weibull model. Thus, solid dispersions obtained with PVP k-30 and P407 proved to be advantageous to enhance aqueous solubility and stability of UA. |
id |
USP-31_63fafb536140f466dfad17e6b90e4b01 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/211846 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid releaseUrsolic acidSolid dispersionsSolvent methodWater-solubilitySolid dispersions (SDs) of ursolic acid (UA) were developed using polyvinylpyrrolidone K30 (PVP K30) in combination with non-ionic surfactants, such as D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) or poloxamer 407 (P407) with the aim of enhancing solubility and in vitro release of the UA. SDs were investigated using a 24 full factorial design, subsequently the selected formulations were characterized for water solubility, X-ray diffractometry (XRD), differential scanning calorimetry (DSC), particle diameter, scanning electron microscopy, drug content, physical-chemical stability and in vitro release profile. SDs showed higher UA water-solubility than physical mixtures (PMs), which was attributed by transition of the drug from crystalline to amorphous or molecular state in the SDs, as indicated by XRD and DSC analyses. SD1 (with P407) and SD2 (with TPGS) were chosen for further investigation because they had higher drug load. SD1 proved to be more stable than SD2, revealing that P407 contributed to ensure the stability of the UA. Furthermore, SD1 and SD2 increased UA release by diffusion and swelling-controlled transport, following the Weibull model. Thus, solid dispersions obtained with PVP k-30 and P407 proved to be advantageous to enhance aqueous solubility and stability of UA.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-04-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21184610.1590/s2175-97902023e21217Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21217Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21217Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e212172175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/211846/194563https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessAndressa Maria PironiJosimar de Oliveira EloyCamila Fernanda RoderoSelma Gutierrez AntonioJovan Duran AlonsoMarlus Chorilli2023-05-29T20:20:21Zoai:revistas.usp.br:article/211846Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-29T20:20:21Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release |
title |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release |
spellingShingle |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release Andressa Maria Pironi Ursolic acid Solid dispersions Solvent method Water-solubility |
title_short |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release |
title_full |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release |
title_fullStr |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release |
title_full_unstemmed |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release |
title_sort |
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release |
author |
Andressa Maria Pironi |
author_facet |
Andressa Maria Pironi Josimar de Oliveira Eloy Camila Fernanda Rodero Selma Gutierrez Antonio Jovan Duran Alonso Marlus Chorilli |
author_role |
author |
author2 |
Josimar de Oliveira Eloy Camila Fernanda Rodero Selma Gutierrez Antonio Jovan Duran Alonso Marlus Chorilli |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Andressa Maria Pironi Josimar de Oliveira Eloy Camila Fernanda Rodero Selma Gutierrez Antonio Jovan Duran Alonso Marlus Chorilli |
dc.subject.por.fl_str_mv |
Ursolic acid Solid dispersions Solvent method Water-solubility |
topic |
Ursolic acid Solid dispersions Solvent method Water-solubility |
description |
Solid dispersions (SDs) of ursolic acid (UA) were developed using polyvinylpyrrolidone K30 (PVP K30) in combination with non-ionic surfactants, such as D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) or poloxamer 407 (P407) with the aim of enhancing solubility and in vitro release of the UA. SDs were investigated using a 24 full factorial design, subsequently the selected formulations were characterized for water solubility, X-ray diffractometry (XRD), differential scanning calorimetry (DSC), particle diameter, scanning electron microscopy, drug content, physical-chemical stability and in vitro release profile. SDs showed higher UA water-solubility than physical mixtures (PMs), which was attributed by transition of the drug from crystalline to amorphous or molecular state in the SDs, as indicated by XRD and DSC analyses. SD1 (with P407) and SD2 (with TPGS) were chosen for further investigation because they had higher drug load. SD1 proved to be more stable than SD2, revealing that P407 contributed to ensure the stability of the UA. Furthermore, SD1 and SD2 increased UA release by diffusion and swelling-controlled transport, following the Weibull model. Thus, solid dispersions obtained with PVP k-30 and P407 proved to be advantageous to enhance aqueous solubility and stability of UA. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-04-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/211846 10.1590/s2175-97902023e21217 |
url |
https://www.revistas.usp.br/bjps/article/view/211846 |
identifier_str_mv |
10.1590/s2175-97902023e21217 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/211846/194563 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21217 Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21217 Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21217 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222918029869056 |